Ferumoxytol is an intravenous iron oxide nanoparticle formulation that has been approved by the US Food and Drug Administration (FDA) for treating anemia in patients with chronic …
SZF Phua, G Yang, WQ Lim, A Verma, H Chen… - ACS …, 2019 - ACS Publications
Photodynamic therapy (PDT) as a treatment method has many advantages such as minimal invasiveness, repeatable dosage, and low systemic toxicity. Issues with conventional PDT …
AA Ansari, VK Thakur, G Chen - Coordination Chemistry Reviews, 2021 - Elsevier
Functionalized upconversion nanoparticles (UCNPs) have perceived massive success in the area of bio-photonic applications. UCNPs are extensively used as a successful emitter in …
C Shi, M Li, Z Zhang, Q Yao, K Shao, F Xu, N Xu, H Li… - Biomaterials, 2020 - Elsevier
Photodynamic therapy (PDT) and chemotherapy has been applied as a prospective approach in tumor therapeutics. However, suffering from the inherent hypoxia status in tumor …
K Wang, M Jiang, J Zhou, Y Liu, Q Zong, Y Yuan - ACS nano, 2022 - ACS Publications
Hypoxia, a common feature of most solid tumors, causes severe tumor resistance to chemotherapy and immunotherapy. Herein, a tumor-acidity and bioorthogonal chemistry …
In widespread progress of nanoparticles (NPs) based biomedical applications particularly in leukemia cancer treatment. Upconversion nanoparticles (UCNPs) demonstrated outstanding …
MP Krafft, JG Riess - Advances in colloid and interface science, 2021 - Elsevier
After the protocol-related indecisive clinical trial of Oxygent, a perfluorooctylbromide/ phospholipid nanoemulsion, in cardiac surgery, that often unduly assigned the observed …
W Zai, L Kang, T Dong, H Wang, L Yin, S Gan, W Lai… - ACS …, 2021 - ACS Publications
Hypoxia is one of the most important factors that limit the effect of radiotherapy, and the abundant H2O2 in tumor tissues will also aggravate hypoxia-induced radiotherapy …
Nanotheranostics is one of the biggest scientific breakthroughs in nanomedicine. Most of the currently available diagnosis and therapies are invasive, time-consuming, and associated …